
Exploiting second-order advantage from mathematically modeled voltammetric data for simultaneous determination of multiple antiparkinson agents in the presence of uncalibrated interference
Keywords: Antiparkinson agents; Multi-way calibration; Second-order advantage; Simultaneous determination; Uncalibrated interference; PD; Parkinson's disease; DPA; dopamine; LDP; levodopa; carbidopa; CDP; MDP; methyldopa; BA; benserazide; TOL; tolcapone; ENT; entac